70 related articles for article (PubMed ID: 2430704)
1. Tumor markers for cancer detection. I.
Pluygers EP; Beauduin MP; Baldewyns PE; Burion JA
Cancer Detect Prev; 1986; 9(5-6):495-504. PubMed ID: 2430704
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers for cancer detection. II.
Pluygers EP; Beauduin MP; Baldewyns PE; Burion JA
Cancer Detect Prev; 1986; 9(5-6):505-9. PubMed ID: 3490909
[TBL] [Abstract][Full Text] [Related]
3. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
[TBL] [Abstract][Full Text] [Related]
4. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444
[No Abstract] [Full Text] [Related]
5. [CEA, HCG-beta and alpha fetoproteins - clinical significance as tumor markers].
Nagel R; Borgmann V; Kemper JD
Helv Chir Acta; 1981 Aug; 48(3-4):433-43. PubMed ID: 6169686
[TBL] [Abstract][Full Text] [Related]
6. [Concentration of carcinoembryonic antigen, alpha-fetoprotein and beta-subunit of human chorionic gonadotropin in serum of workers employed directly in the production of coke].
Snit M
Med Pr; 1993; 44(1):21-8. PubMed ID: 7684110
[TBL] [Abstract][Full Text] [Related]
7. [Significance of serum ferritin level in testicular tumors].
Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
[TBL] [Abstract][Full Text] [Related]
8. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies].
Ohashi T; Tohjoh S; Takeda K; Kumon H; Morioka M; Matsumura Y; Ohmori H; Suyama B; Hironaka K
Hinyokika Kiyo; 1983 Feb; 29(2):141-53. PubMed ID: 6375313
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of HCG and hCG beta determinations.
Mann K; Saller B; Hoermann R
Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
[TBL] [Abstract][Full Text] [Related]
11. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
12. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers in the diagnosis of lung cancer].
Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
[TBL] [Abstract][Full Text] [Related]
14. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
[TBL] [Abstract][Full Text] [Related]
15. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma.
Uçkaya G; Ozet A; Arpaci A; Kömürcü S
Nuklearmedizin; 1998; 37(8):297-8. PubMed ID: 9868713
[TBL] [Abstract][Full Text] [Related]
17. Tumour markers.
Pandha HS; Waxman J
QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in focal and diffuse liver diseases].
Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of examination of some tumor markers in diagnostics of liver cancer.
Snarska J; Szajda SD; Puchalski Z; Szmitkowski M; Chabielska E; Kaminski F; Zwierz P; Zwierz K
Hepatogastroenterology; 2006; 53(68):271-4. PubMed ID: 16608038
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor marker determinations in testicular cancer patients.
Kühböck J; Aiginger P; Kuzmits R; Spona J
Cancer Detect Prev; 1987; 10(5-6):389-92. PubMed ID: 2436782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
